Salem Investment Counselors Inc Novartis Ag Transaction History

Salem Investment Counselors Inc

$3.24 Billion
Q3 2024

A detailed history of Salem Investment Counselors Inc transactions in Novartis Ag stock. As of the latest transaction made, Salem Investment Counselors Inc holds 6,362 shares of NVS stock, worth $703,382. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,362

Previous 6,362 -0.0%

Holding current value

$703,382

Previous $677,000 7.98%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$92.57 - $107.37 $6,479 - $7,515	-70 Reduced 1.09%	6,362 $677,000
Q1 2024 Apr 11, 2024	SELL	$95.27 - $108.47 $952 - $1,084	-10 Reduced 0.16%	6,432 $622,000
Q4 2023 Jan 16, 2024	BUY	$92.27 - $101.54 $92,085 - $101,336	998 Added 18.33%	6,442 $650,000
Q3 2023 Oct 04, 2023	BUY	$94.73 - $105.13 $2,652 - $2,943	28 Added 0.52%	5,444 $554,000
Q2 2023 Jul 19, 2023	BUY	$92.52 - $104.91 $4,533 - $5,140	49 Added 0.91%	5,416 $546,000
Q1 2023 May 11, 2023	SELL	$80.03 - $92.81 $4,001 - $4,640	-50 Reduced 0.92%	5,367 $493,000
Q4 2022 Feb 15, 2023	BUY	$75.55 - $92.52 $9,066 - $11,102	120 Added 2.27%	5,417 $491,000
Q3 2022 Nov 09, 2022	SELL	$74.61 - $87.26 $6,341 - $7,417	-85 Reduced 1.58%	5,297 $403,000
Q2 2022 Aug 17, 2022	BUY	$80.52 - $93.75 $49,197 - $57,281	611 Added 12.81%	5,382 $455,000
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $18,184 - $20,570	-227 Reduced 4.54%	4,771 $419,000
Q4 2021 Feb 15, 2022	BUY	$79.7 - $88.13 $2,151 - $2,379	27 Added 0.54%	4,998 $437,000
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $16,356 - $19,028	200 Added 4.19%	4,971 $407,000
Q2 2021 Aug 17, 2021	SELL	$85.24 - $94.15 $6,222 - $6,872	-73 Reduced 1.51%	4,771 $435,000
Q1 2021 May 17, 2021	BUY	$83.5 - $98.47 $25,133 - $29,639	301 Added 6.63%	4,844 $414,000
Q4 2020 Feb 17, 2021	BUY	$78.07 - $94.43 $6,167 - $7,459	79 Added 1.77%	4,543 $429,000
Q2 2020 Aug 13, 2020	BUY	$80.93 - $91.1 $1,618 - $1,822	20 Added 0.45%	4,464 $390,000
Q2 2018 Aug 15, 2018	SELL	$64.91 - $73.36 $116,838 - $132,048	-1,800 Reduced 28.83%	4,444 $336,000
Q3 2017 Nov 16, 2017	BUY	$74.14 - $77.27 $462,930 - $482,473	6,244	6,244 $538,000

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.55M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $238B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.

Account

Salem Investment Counselors Inc Novartis Ag Transaction History